Verition Fund Management
AXNX

Verition Fund Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Verition Fund Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-153,354
Closed -$10.7M – 3609
2024
Q3 		$10.7M Buy
+153,354
New +$10.5M 0.05% 377
2024
Q2 		– Sell
-147,364
Closed -$10.2M – 3341
2024
Q1 		$10.2M Buy
+147,364
New +$9.94M 0.07% 332
2023
Q4 		– Sell
-5,663
Closed -$318K – 2746
2023
Q3 		$318K Buy
+5,663
New +$319K ﹤0.01% 1696
2021
Q3 		– Sell
-3,759
Closed -$238K – 2381
2021
Q2 		$238K Buy
+3,759
New +$222K ﹤0.01% 1474

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Verition Fund Management's AXNX Position: Q4 2024 in Review

Verition Fund Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 153,354 shares — an estimated $10.7M sold.

Verition Fund Management first reported a position in AXNX in Q2 2021 and held it in 4 quarters. The position peaked at $10.7M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Verition Fund Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 153,354 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $10.7M.
  • Verition Fund Management first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Verition Fund Management's Axonics, Inc. Common Stock position peaked at $10.7M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.